论文部分内容阅读
目的研究分析对无痛人流术患者采用米索前列醇舌下含服的临床疗效,为其临床研究提供科学依据。方法回顾性分析2010年3月～2013年3月我站收治的240例早孕并采用无痛人流术治疗患者的临床资料,对照组患者(120例)临床期间采用丙泊酚联合芬太尼治疗,观察组患者(120例)在上述治疗的基础上给予米索前列醇舌下含服治疗,比较两组患者的治疗效果。结果经临床观察比较,观察组患者的优秀率为93.3%,对照组为53.3%,观察组明显优于对照组,组间比较差异明显,具有统计学意义(P<0.05)。结论对无痛人流患者临床期间给予米索前列醇舌下含服能显著减少术中出血量,宫缩效果明显,且操作简便,安全性强,值得临床关注。
Objective To study the clinical efficacy of misoprostol sublingual delivery in patients with painless abortion and provide a scientific basis for its clinical study. Methods Retrospective analysis of 240 cases of early pregnancy treated with painless abortion in our hospital from March 2010 to March 2013 were retrospectively analyzed. Patients in the control group (120 cases) were treated with propofol combined with fentanyl The patients in the observation group (120 cases) were given misoprostol sublingual therapy on the basis of the above treatment, and the treatment effect was compared between the two groups. Results The clinical observation showed that the excellent rate of the observation group was 93.3% and that of the control group was 53.3%. The observation group was significantly better than the control group. The difference between the two groups was significant and statistically significant (P <0.05). Conclusion The sublingual administration of misoprostol during the clinical course of painless abortion patients can significantly reduce the amount of intraoperative bleeding, the effect of contractions is obvious, and the operation is simple and safe. It deserves clinical attention.